DailyIQ
Last updated2 minutes ago

EMN·Eastman Chemical Company

$62.98
+0.88 (+1.42%)
Overnight$63.00+0.02 (+0.03%)
High
$63.07
Open
$62.10
Market Cap
7.19B
52W High
$83.47
Low
$61.75
P. Close
$62.98
P/E
16.27
52W Low
$55.35
Fwd P/E
9.38
DailyIQ Est.
$78.63
Inst. Ownership
44.7%
Short Interest
5.84%
Days to Cover
5.3
Div. Yield
5.33%
Next Ex-Div
~Dec 15
Div. Growth
16+ yrs
Technical Score (1D)
14
BEARISH
News Sentiment
59
BULLISH
On Oct 13, Barclays analyst Aleksey Yefremov initiated coverage of Eastman Chemical (EMN) with an equal‑weight rating and set a price target of $72, indicating a modest upside to the company’s current fundamentals. On the same day, RBC Capital’s Arun Viswanathan lowered EMN’s price target from $74 to $65 while keeping the rating at Sector Perform, reflecting a reassessment of the company’s valuation relative to peers. Earlier on Oct 13, an article highlighted Eastman’s operational improvements, noting a 23% rise in 2Q26 AEPS and a 16% increase in EBIT, yet the market remained bearish with a 7‑8x P/E multiple. Analysts maintained a Buy recommendation, citing cost savings, volume recovery, and molecular recycling as drivers of future earnings potential. The company’s strong balance sheet and dividend yield above 5.4% were also highlighted as risk‑mitigating factors.
LOW TARGET
$65 +3.2%
2 analysts
MEAN TARGET
$77 +22.5%
13 analysts
HIGH TARGET
$87 +38.1%
9 analysts
PRICE RANGE
$65.00 - $87.00
SB / B / H / S / SS
6/7/9/1/1
DAILYIQ EST.
$78.63 (+24.8%)
Sector
Basic Materials
Industry
Specialty Chemicals
Exchange
NYQ
Country
United States
Symbol
EMN
Description
Eastman Chemical Company is a global specialty materials company, delivering innovative solutions across diverse industries. The company's core business revolves around four key segments: Additives & Functional Products, Advanced Materials, Chemical Intermediates, and Fibers. Eastman's value proposition lies in its ability to provide specialized materials, including polymers, additives, and intermediates, that enhance product performance and functionality across sectors like transportation, consumer goods, and construction. Its diverse product portfolio and international presence, including operations in the United States and China, position it as a key supplier to a wide range of end markets. Founded in 1920, Eastman Chemical Company is headquartered in Kingsport, Tennessee.
Bought (1Y)
0 shares
$0
Sold (1Y)
4,341 shares
$314K
Haynesworth Linnie M-
Award/Grant480 shares2026-10-07
HORNBAKER RENEE J-
Award/Grant480 shares2026-10-07
Alfonso Humberto P-
Award/Grant480 shares2026-10-07
Alfonso Humberto P-
Award/Grant1,162 shares2026-10-07
OBRIEN JAMES J /KY-
Award/Grant480 shares2026-10-07
63/ 100
Neutral / mixed
Overall: Neutral
✕Revenue declining year over year
✓Positive net margin
✓Positive operating cash flow
Gross Margin
21.1%
Net Margin
5.4%
Revenue CAGR
1.4%
Current Ratio
1.37x
Debt / Equity
0.80x
Return on Equity
8.0%
Earnings Summary
Eastman Chemical Company (EMN) is a global specialty materials firm headquartered in Kingsport, Tennessee, operating across four key segments—Additives & Functional Products, Advanced Materials, Chemical Intermediates, and Fibers—serving transportation, consumer goods, and construction markets worldwide. As a leading player in the Basic Materials sector, Eastman leverages its diversified portfolio to deliver polymers and functional additives that enhance product performance across diverse end‑markets. In the most recent quarters, the company posted a Q4 2025 revenue of $1.973 billion, slightly below the $2.039 billion estimate, and an EPS of $0.75 versus the $0.728 forecast, indicating a modest earnings beat amid a revenue decline. The following Q1 2026 results showed revenue of $2.177 billion against a $2.189 billion estimate and EPS of $1.09 versus $1.072, again a small earnings beat but with revenue falling short of expectations. Compared to the prior two quarters (Q2 2025 and Q3 2025), where revenue hovered around $2.287 billion and $2.202 billion respectively, Eastman experienced a gradual revenue contraction of roughly 5% year‑over‑year, while EPS dipped from $1.6 in Q2 2025 to $1.14 in Q3 2025 before rebounding to $0.75 in Q4 2025. Historically, the company has maintained a steady YoY revenue growth trajectory of 3–4% over the past three years, with EPS growth fluctuating around 2–3% annually; it has consistently beat analyst estimates in 3 of the last 4 quarters, though revenue misses have occasionally offset earnings gains. Recent news indicates that Eastman is preparing to release its Q3 2026 results, with no new guidance disclosed, while UBS and Mizuho have modestly lowered their price targets, reflecting a cautious but still positive view of the company’s fundamentals.

EPS

EstBeatMiss
$0.54$0.95$1.35$1.75$2.16Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.92 - -
Q2'26$1.82$1.97+8.2%
Q1'26$1.07$1.09+1.7%
Q4'25$0.73$0.75+3.1%
Q3'25$1.17$1.14-2.2%
Q2'25$1.75$1.60-8.7%

Revenue

EstBeatMiss
$1.9B$2.1B$2.2B$2.4B$2.6BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$2.5B - -
Q2'26$2.4B$2.5B+4.7%
Q1'26$2.2B$2.2B-0.6%
Q4'25$2.0B$2.0B-3.2%
Q3'25 - $2.2B -
Q2'25 - $2.3B -

Market Data

EMN Stock Snapshot

BEARISH14/100
$63.00+$0.02 (0.0%)
Market cap
7.19B
P/E ratio
16.3
Day range
$61.75 – $63.07
News sentiment
59/100 · Neutral
Analyst target
$77.19 (+22.5%)
Consensus
Hold · 24 analysts
52-week range+13.8% off low · -24.5% from high
$55.35$83.47
Price $63.00 DailyIQ Est. $78.63

Eastman Chemical Company is trading in the lower half of its 52-week range with momentum still pointing lower. At this size, a single catalyst moves the stock further than it would a larger peer.

Reverse DCF

What growth is priced into EMN?

RICH

At today's price, Eastman Chemical Company needs to grow free cash flow about 25.3% a year for the next 10 years to justify its valuation at a 8.49% cost of capital. Over its actual history it has compounded free cash flow at 9.0% a year, so the market is asking for 16.3 percentage points above its own delivered rate. On that basis EMN looks priced above what its own growth record supports.

Implied FCF growth
25.3%
Historical FCF CAGR
9.0%
Growth gap
+16.3 pts
Verdict
RICH
Discount rate (WACC)
8.49%
Beta
1.04

Behaviour On Record

What EMN's own history says about today's numbers

Realized volatility (21d)
19.0% 19th pct
Below its peak
-51.8%
vs 200-day average
-11.8%
Up days (1y)
48%

Eastman Chemical Company is currently running 19.0% annualised volatility over the last 21 sessions. Measured against EMN's own 13 years of daily returns rather than a market-wide average, that is the 19th percentile — unusually subdued by its own history, against a typical reading of 26.7%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

EMN is trading -51.8% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -24.5%, and the deepest was -50.9% in 2020. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.

Price sits -11.8% from its 200-day moving average. Against every other day in its history, that gap ranks at the 18th percentile — a narrower gap than it typically runs. Over the past year EMN closed higher on 48% of sessions, and it is currently 1 session into a falling streak.

On October specifically: over 13 years of records, EMN finished the month higher 8 of 13 times, with a median return of +1.5% and an average of +0.6%. Its strongest month historically has been November at +4.0% on average, its weakest September at -3.0%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: EMN has opened more than 2% away from the prior close in 153 of 3,266 sessions (4.7% of the time), with the largest gaps running +11.1% and -16.0%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, EMN moved an average of 3.6% in the session after earnings, closing higher 2 of those 3 times, with a median move of +4.0% and a largest of +6.6%.

All figures computed from 3,267 daily closes between 2013-10-14 and 2026-10-09, split-adjusted, recomputed daily. Percentiles are against EMN's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of EMN's sector?

Eastman Chemical Company sits in the Materials sector, currently ranked 9th of 12 GICS sectors by relative-strength rotation score (improving).

Sector rank
#9 of 12
Sector state
Improving
Sector rotation score
9

Analyst Rating Changes

Are analysts turning bullish or bearish on EMN?

RBC Capital most recently reiterated its rating on Eastman Chemical Company to Sector Perform on Oct 13, 2026 with a price target of $65 (from $74). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
RBC Capital — Sector Perform
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Oct 13, 2026RBC CapitalMaintainedSector Perform$74 → $65
Oct 13, 2026BarclaysInitiatedEqual-Weight$72
Oct 5, 2026UBSMaintainedBuy$92 → $77
Oct 1, 2026MizuhoMaintainedOutperform$85 → $80
Sep 30, 2026CitigroupMaintainedBuy$81 → $76
Sep 11, 2026KeybancInitiatedSector Weight-
Aug 5, 2026RBC CapitalMaintainedSector Perform$69 → $74
Aug 3, 2026UBSMaintainedBuy$89 → $92
Aug 3, 2026CitigroupMaintainedBuy$85 → $81
Jul 2, 2026Morgan StanleyMaintainedOverweight$83 → $79
Jun 24, 2026CitigroupMaintainedBuy$88 → $85
May 5, 2026Morgan StanleyMaintainedOverweight$73 → $83

Peers & ETF holders

EMN peers & ETF holders

News Sentiment Analysis

Sentiment gathered from recent headlines

59/100
Strong NegativeNeutralStrong Positive
MODERATELY BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
The article highlighted Eastman Chemical’s (EMN) recent operational improvements, noting a 23% rise in 2Q26 AEPS and a 16% increase in EBIT. Despite these gains, the market remains bearish, reflected in a depressed 7‑8x P/E multiple. Analysts reaffirmed a Buy recommendation, citing cost savings, volume recovery, and molecular recycling as drivers of future earnings potential. The company’s strong balance sheet and dividend yield above 5.4% were also highlighted as risk‑mitigating factors.
What did this article say?
RBC Capital analyst Arun Viswanathan reduced Eastman Chemical’s (EMN) price target from $74 to $65 while keeping the rating at Sector Perform. The downgrade reflects a reassessment of the company’s valuation relative to peers. The move signals a modest negative outlook for EMN’s stock, though the rating remains unchanged.
What did this article say?
Barclays analyst Aleksey Yefremov initiated coverage on Eastman Chemical (EMN) with an equal‑weight rating on October 13. The firm announced a price target of $72, signaling a neutral to slightly positive outlook for the company. The coverage launch reflects confidence in EMN’s current fundamentals and growth prospects, though it does not represent a significant shift in market sentiment. The announcement may influence investor perception and trading activity, but it is not a transformative catalyst.
What did this article say?
Eastman Chemical Company scheduled the release of its third‑quarter 2026 financial results, accompanied by a SEC Form 8‑K filing, a teleconference, and a webcast. The announcement was issued via a Business Wire press release on October 6, 2026. No guidance or earnings preview was provided, and the company did not disclose any material changes to its financial outlook. The disclosure is a routine update that informs investors of the upcoming earnings event. The timing of the release does not indicate any significant shift in the company’s financial performance or strategy.
What did this article say?
UBS analyst Joshua Spector reduced Eastman Chemical’s (EMN) price target from $92 to $77 while keeping a Buy recommendation. The downgrade reflects concerns over the company’s earnings outlook and competitive pressures in the chemical sector. The move signals a potential short‑term negative pressure on the stock price. The decision highlights the firm’s assessment of EMN’s valuation relative to peers.
What did this article say?
UBS reduced its price target for Eastman Chemical (EMN) from $92 to $77 while keeping a buy recommendation. The downgrade reflects a reassessment of the company’s valuation relative to peers. The rating remains positive, indicating confidence in the company’s fundamentals. The target cut suggests a modest downward adjustment in expected earnings growth. The change is expected to influence short‑term investor sentiment.
What did this article say?
Mizuho analyst John Roberts maintained an Outperform rating for Eastman Chemical (NYSE:EMN) but reduced the price target from $85 to $80. The downgrade reflects a more cautious view of the company's near‑term earnings prospects. The adjustment signals that the bank expects slower growth or higher risk than previously anticipated. This change may influence investor sentiment and trading activity around EMN shares. The rating remains positive, but the lowered target indicates a modest negative shift in expectations.
What did this article say?
Mizuho reduced its price target for Eastman Chemical (EMN) from $85 to $80, citing a reassessment of the company’s valuation. The bank retained an Outperform rating, indicating it still views the stock as a buying opportunity. The downgrade in target price reflects a more cautious outlook on future earnings growth and market conditions. This adjustment may temper investor enthusiasm but does not alter the overall positive stance on the company’s fundamentals. The change signals a modest negative shift in analyst sentiment toward EMN.
What did this article say?
Citigroup analyst Patrick Cunningham retained a Buy recommendation for Eastman Chemical (EMN) while reducing the price target from $81 to $76. The downgrade reflects a more conservative view of the company’s near‑term earnings outlook, though the rating itself remains positive. The move signals a modest headwind for the stock but does not alter the overall bullish stance.
What did this article say?
Eastman Chemical Co. (EMN) has announced a $0.84 per share dividend payable on October 7, 2026, with an ex‑dividend date of September 15, 2026. The payout reflects the company’s ongoing focus on higher‑margin specialty chemicals and its strategy of divesting noncore assets. The dividend aligns with EMN’s historical payout trend and is expected to be sustainable given its stable cash flow from global specialty product sales. No immediate impact on earnings guidance or strategic direction is indicated, and the announcement is largely routine for investors. The key takeaway for traders is that the dividend is a standard cash return to shareholders without altering the company’s operational outlook.

Technical Analysis

Real-time indicators across multiple timeframes

14
BEARISH
Momentum rank against about 1,000 stocks and ETFs for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $3.36B combined position · 19 adding, 6 trimming, 0 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
BlackRock, Inc.▲ Buy16,936,70914.84%$1.13B2026-08-07
Vanguard Group Inc▼ Sell13,272,16511.63%$847.16M2026-01-29
Morgan Stanley▲ Buy3,330,7322.92%$223.09M2026-08-13
Bank of America Corp▲ Buy2,469,9762.16%$165.44M2026-08-14
Capital Research Global Investors▼ Sell2,190,3681.92%$146.71M2026-08-12
Geode Capital Management, LLC▲ Buy2,065,4921.81%$138.40M2026-08-12
Two Sigma Investments, LP▲ Buy1,603,0731.40%$107.37M2026-08-14
Marshall Wace, LLP▲ Buy1,412,1881.24%$94.59M2026-08-13
Norges Bank▼ Sell1,325,6851.16%$88.79M2026-08-12
Goldman Sachs Group Inc▲ Buy1,226,0311.07%$82.12M2026-08-14
Northern Trust Corp▲ Buy992,0220.87%$66.45M2026-08-13
Invesco Ltd.▲ Buy706,8340.62%$47.34M2026-08-14
AQR Capital Management LLC▼ Sell460,6370.40%$30.63M2026-08-14
FMR LLC (Fidelity)▼ Sell451,5990.40%$30.25M2026-08-13
JPMorgan Chase & Co▲ Buy425,2320.37%$28.80M2026-08-12
Gotham Asset Management, LLC▲ Buy398,4840.35%$26.69M2026-08-14
Citadel Advisors LLC▲ Buy308,2560.27%$20.65M2026-09-02
Wells Fargo & Company▲ Buy269,0260.24%$18.02M2026-08-14
Point72 Asset Management, L.P.▲ New224,7280.20%$15.05M2026-08-14
AllianceBernstein L.P.▲ Buy151,2540.13%$11.54M2026-08-14
Citigroup Inc▲ Buy147,0360.13%$9.85M2026-08-03
Renaissance Technologies LLC▲ Buy129,8400.11%$8.70M2026-08-13
Millennium Management LLC▼ Sell109,7310.10%$7.35M2026-08-14
Prudential Financial Inc▲ Buy104,0850.09%$6.97M2026-08-12
Man Group plc▲ Buy81,6740.07%$5.47M2026-08-14
Q2 2026 flow:3.70M sh bought ($248.55M)3.23M sh sold ($216.43M)net +466.1K sh (+$32.12M)
Congressional Trading Activity
3 disclosed trades · ~$24.0K est. traded value · 1 buys, 2 sells
MemberChamberStateTypeAmountTradedFiled
Lisa McClainHouseMI09▼ Sell$1K - $15K2025-08-042025-09-12
Lisa McClainHouseMI09▲ Buy$1K - $15K2025-06-172025-08-13
Rob BresnahanHousePA08▼ Sell$1K - $15K2025-05-152025-06-09